《药学杂志》本周精选：避孕、肥胖不平等及 GLP-1 药物对进食障碍的影响
《药学杂志》每周精选本周值得关注的药学与健康新闻。本周，《药学杂志》报道了一种延缓 1 型糖尿病症状的药物，详细介绍了社区药房的 B 型脑膜炎球菌疫苗接种活动，围绕一种抗癫痫药物的“过高”定价引发了新的讨论，为“PATHWAYS”青春期阻滞剂试验设定了最低年龄，并紹介了一个由药剂师和牙医领导的戒烟诊所，该诊所取得了 20% 的戒烟率。更多本周您可能错过的健康新闻，请继续阅读。本周，英国国家健康与临床卓越研究所 (NICE) 推荐将西米普利尤单抗（Libtayo；Regeneron）作为一种治疗方案，用于铂类化疗后出现复发或转移性宫颈癌的成年患者。此外，NICE 推荐将已获批用于持续性、复发性或转移性宫颈癌的帕博利珠单抗，更早地应用于疾病治疗途径，作为未经治疗的局部晚期宫颈癌成年患者常规一线治疗选择。
Security Technology Expert
Convenient interactive features are a major highlight of the platform. Users can easily access match information, participate in discussions, and share viewing pleasures with other fans, jointly building a vibrant football community.
Senior Fan Commentator
Active Community User
As the official live streaming platform under 2026 FIFA World Cup Security Technology Co., Ltd., we have been committed to providing users with a secure, reliable, and seamless World Cup viewing experience since our establishment in 2015. We continuously optimize match resource coverage and platform performance, striving to offer every user an excellent viewing experience.
View Full Profile
Senior Fan
In addition to match live streaming, the platform also gathers the latest updates and in-depth match analysis of popular teams worldwide. Our expert team will interpret tactics and predict match outcomes, helping you understand the games more deeply.
In-depth Match Analyst
The 2026 FIFA World Cup live streaming platform boasts a secure and stable platform architecture, strictly protecting user data security and privacy. We adhere to the principle of “Safety and Reliability, User First,” and are committed to creating a trustworthy viewing environment for you.